Welcome to CMEZone

CMEZone.com is a full-service web solution that provides timely, practical, and clinically relevant continuing education for health care professionals. All CMEZone activities are designed to enhance clinical knowledge and competence and to improve patient care.

More than 100,000 health care professionals maintain membership in CMEZone in order to access continuing education activities on demand. All activities are easily accessible, free of charge and offer participants instantaneous post-test grading and printable certificates of completion.

CMEZone is operated by Applied Clinical Education (ACE). As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens performance and enhances the clinical care of patients.

Participant Login


Remember Me
Lost your password? New user? Register here

Jointly sponsored by Global Education Group and Applied Clinical Education

  • GEGLogo
  • CMEZoneLogo

Supported by an educational grant from

  • CovidenLogo

The REMEDIES Coalition also includes

  • ASPELogo
  • iMDLogo
  • MedMatrxLogo
  • NAMCPLogo
  • REALCMELogo

 



Approximately 30% to 50% of U.S. adults do not adhere to their long-term medications, resulting in an estimated $100 billion in avoidable costs every year (JAMA... The FDA has approved Hysingla ER,  the first and only hydrocodone product with abuse-deterrent properties. The developers of a new app hope to improve pediatric pain management by eliminating the time and number of steps it takes to calculate medication dosages. Transforaminal and interlaminar epidural steroid injections (TFESI and ILESI, respectively) have minimal immediate and delayed complication rates when performed... The National Heart, Lung, and Blood Institute (NHLBI) recently released new recommendations for managing chronic pain in people with sickle cell disease (SCD). Information technology tools can help busy clinicians keep pace with the flood of boxed warnings issued for drugs annually.